← Back to headlines
Medical Breakthrough: New Antibodies Developed Against Epstein-Barr Virus
Scientists have developed new antibodies targeting the Epstein-Barr virus (EBV), a highly prevalent virus affecting an estimated 95% of adults worldwide. While often asymptomatic, EBV is not merely a short-term infection.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.